Compare TEAM & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEAM | IDXX |
|---|---|---|
| Founded | 2002 | 1983 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6B | 51.1B |
| IPO Year | 2015 | 1991 |
| Metric | TEAM | IDXX |
|---|---|---|
| Price | $162.20 | $700.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 10 |
| Target Price | $251.76 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 2.4M | 605.3K |
| Earning Date | 01-29-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.65 |
| EPS | N/A | ★ 12.60 |
| Revenue | ★ $5,460,076,000.00 | $4,167,411,000.00 |
| Revenue This Year | $23.41 | $12.15 |
| Revenue Next Year | $18.57 | $8.79 |
| P/E Ratio | ★ N/A | $55.89 |
| Revenue Growth | ★ 19.51 | 8.39 |
| 52 Week Low | $139.70 | $356.14 |
| 52 Week High | $326.00 | $769.98 |
| Indicator | TEAM | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 49.31 |
| Support Level | $158.26 | $693.72 |
| Resistance Level | $164.84 | $716.45 |
| Average True Range (ATR) | 4.54 | 17.46 |
| MACD | 1.65 | -5.83 |
| Stochastic Oscillator | 85.98 | 13.64 |
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.